Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | NAMPT | P43490 | 2/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12529291 | 0.86 | L3MBTL1 (0.60) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL28132033 | 0.85 | L3MBTL1 (0.72) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL2202547 | 0.84 | L3MBTL1 (0.60) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| Trifluoroacetic Acid SCHEMBL2204433 | 0.81 | L3MBTL1 (0.56) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL20764120 | 0.80 | EPHX2 (0.59) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL6678035 | 0.79 | LMNA (0.65) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL1588043 | 0.79 | L3MBTL1 (0.64) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL14625554 | 0.79 | L3MBTL1 (0.64) | L3MBTL1LMNAPTBP1HTTKLF5 | |
| SCHEMBL20764082 | 0.78 | MEN1 (0.58) | L3MBTL1SMN1; SMN2EPHX2NPC1RAB9A | |
| SCHEMBL12529828 | 0.78 | NPC1 (0.62) | L3MBTL1LMNAPTBP1HTTKLF5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616459-A1 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS I | BASF SE (DE) | 2013-07-24 | — | — | EP | claimed |
| WO-2012034961-A1 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS I | BASF SE (DE) | 2012-03-22 | — | — | WO | claimed |
| EP-2616459-B1 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS I | BASF SE (DE) | 2016-05-04 | — | — | EP | disclosed |
| US-8609700-B2 | Pyridine compounds for controlling invertebrate pests I | BASF SE (DE) | 2013-12-17 | — | — | US | disclosed |
| EP-2616459-A1 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS I | BASF SE (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-20130178502-A1 | Pyridine Compounds for Controlling Invertebrate Pests I | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| WO-2012034961-A1 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS I | BASF SE (DE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178502-A1 | Pyridine Compounds for Controlling Invertebrate Pests I | GRIN2A, PRXL2A, MT-CO2 | L3MBTL1 3173/4885LMNA 2955/4885PTBP1 2923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.